• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Wave Life Sciences Ltd. - Ordinary Shares (NQ:WVE)

    13.84 -0.99 (-6.68%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,743,653
    Open 15.03
    Bid (Size) 13.84 (100)
    Ask (Size) 13.90 (200)
    Prev. Close 14.83
    Today's Range 13.76 - 15.08
    52wk Range 5.280 - 21.73
    Shares Outstanding 98,983,261
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -13.2%
    -13.2%
    1 Month
    -35.1%
    -35.1%
    3 Month
    +69.0%
    +69.0%
    6 Month
    +74.1%
    +74.1%
    1 Year
    +10.7%
    +10.7%

    More News

    Read More
    News headline image
    In today's session, these stocks are experiencing unusual volume. ↗
    Via Chartmill
    News headline image
    Golden Cross Alert: 3 Stocks With Major Upside Potential ↗
    Via MarketBeat
    The 2025 Weight-Loss Drug Gold Rush: How Eli Lilly Pulled Ahead, Novo Hit A Snag — And A Swarm Of Biotech Underdogs Are Closing In ↗
    Via Stocktwits
    Wave Life Sciences Stock Rockets 120% After Obesity Drug Shows Deep Fat Reduction, Muscle Gain — Traders See A ‘Blockbuster' Candidate ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Why Wave Life Sciences Stock Crushed it Again Today ↗
    Via The Motley Fool
    News headline image
    Which stocks have an unusual volume on Tuesday? ↗
    Via Chartmill
    News headline image
    ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active
    Via AB Newswire
    News headline image
    Why Structure Therapeutics Stock Doubled and Then Some on Monday ↗
    Via The Motley Fool
    News headline image
    Why Wave Life Sciences Stock Vaulted 146% Higher on Monday ↗
    Via The Motley Fool
    Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More ↗
    Via The Motley Fool
    News headline image
    Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    Via MarketMinute
    News headline image
    These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results ↗
    Via Benzinga
    News headline image
    Wave Life Sciences (WVE) Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q3 2025 Earnings Miss, Stock Falls ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
    From Wave Life Sciences USA, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Wave Life Sciences Ltd. - Ordinary Shares publicly traded?
    Yes, Wave Life Sciences Ltd. - Ordinary Shares is publicly traded.
    What exchange does Wave Life Sciences Ltd. - Ordinary Shares trade on?
    Wave Life Sciences Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares?
    The ticker symbol for Wave Life Sciences Ltd. - Ordinary Shares is WVE on the Nasdaq Stock Market
    What is the current price of Wave Life Sciences Ltd. - Ordinary Shares?
    The current price of Wave Life Sciences Ltd. - Ordinary Shares is 13.84
    When was Wave Life Sciences Ltd. - Ordinary Shares last traded?
    The last trade of Wave Life Sciences Ltd. - Ordinary Shares was at 01/09/26 04:00 PM ET
    What is the market capitalization of Wave Life Sciences Ltd. - Ordinary Shares?
    The market capitalization of Wave Life Sciences Ltd. - Ordinary Shares is 1.37B
    How many shares of Wave Life Sciences Ltd. - Ordinary Shares are outstanding?
    Wave Life Sciences Ltd. - Ordinary Shares has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.